Buspirone(Acacia)

丁螺环酮（Acacia）

Report date: 2023/04/21 09:51:02

Base Information

Drug NameBuspirone(Acacia)
Drug Alias NameAPD-405
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin (5-HT) receptorDopamine D2 receptor
Therapy Area/IndicationsPostoperative Nausea and Vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanySwitzerland +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAcacia Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcacia Pharma Ltd
Active IndicationsN/A
Inactive IndicationsPostoperative Nausea and Vomiting

Other Information

ATC CodeN/A
Related LinksN/A